How researchers dupe the public with a sneaky practice called "outcome switching"
But that doesn't always happen. "In Study 329," explains
Ben Goldacre, a crusading British physician and author, "none of the pre-specified analyses yielded a positive result for GSK’s drug, but a few of the additional outcomes that were measured did, and those were reported in the academic paper on the trial, while the pre-specified outcomes were dropped."
"When we get the wrong answer, in medicine, that’s not a matter of academic sophistry — it causes avoidable suffering, bereavement, and death. So it’s worth being as close to perfect as we can possibly be."